Sarcopenia and muscle loss in multiple sclerosis patients
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with multiple sclerosis by a neurologist.
- You have not had an MS attack in the last 3 months.
- You can still walk (even if you need a cane or walker).
- You are willing to give consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common muscle loss and weakness are in people with multiple sclerosis (MS) at different stages of the disease. It also checks how muscle loss relates to everyday function. The goal is to better understand these issues to improve care.
This study looks at proteins in the blood to understand muscle loss (sarcopenia) in people with chronic lung disease. It aims to find better ways to detect and manage this condition.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This study looks at how common muscle loss (sarcopenia) is in older people with long-standing type 2 diabetes. It aims to find out if there is a link so that doctors can spot muscle problems earlier and help patients stay stronger.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.